Clinical studies of incretin receptor agonists provide evidence of cardiovascular benefit, but they do not directly demonstrate anti-fibrotic effects, as fibrosis has not been measured as a primary outcome in major trials
Some peptides are broken down quickly, while others are specifically engineered to last longer and provide extended effects
Both Retatrutide and Tesamorelin have shown positive effects on liver fat reduction
Elevated LOXL2 expression in estrogen receptor-negative breast tumors is strongly associated with unfavorable outcomes, including poor prognosis, decreased overall survival, and reduced metastasis-free survival, suggesting that LOXL2 could serve as a valuable prognostic marker for metastasis in breast cancer cases
NAD + , Nicotinamide adenine dinucleotide
Glutathione 500mg with Milk Thistle Extract &